Sergey Jakimov is a Managing Partner at LongeVC, a venture capital fund backing early-stage biotech and longevity-focused founders.
A serial entrepreneur, Sergey has co-founded three deep-tech ventures and raised more than $50 million in funding. He has also partnered with early-stage therapeutics companies on fundraising, IP protection, and clinical trial strategies—particularly in cardiovascular, oncology, and neurodegenerative disease.
Beyond venture, he co-founded Longenesis, a medical tech company unlocking the value of biomedical data to accelerate drug discovery, and the Longevity Science Foundation, a non-profit advancing research to extend healthy human lifespan.
.png)
.png)
.png)